Danaher Corporation $DHR Stock: XML Financial LLC Boosts Holdings

Posted by Brenda Bartman on Nov 4th, 2026

XML Financial LLC lifted its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 459.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,758 shares of the conglomerate’s stock after purchasing an additional 5,551 shares during the quarter. XML Financial LLC’s holdings in Danaher were worth $1,497,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Danaher in the second quarter valued at $10,492,520,000. Jupiter Topco LLC acquired a new stake in Danaher in the 2nd quarter valued at $1,456,317,000. Generation Investment Management LLP bought a new stake in Danaher during the 2nd quarter worth about $1,287,949,000. Bank of America Corp DE bought a new stake in Danaher during the 2nd quarter worth about $993,846,000. Finally, Legal & General Group Plc acquired a new position in shares of Danaher during the 2nd quarter worth about $801,056,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $229.99 on Wednesday. The company has a fifty day moving average price of $219.38 and a two-hundred day moving average price of $201.70. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock has a market cap of $161.80 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.89 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were issued a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

Insider Buying and Selling

In related news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 10.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on DHR shares. Morgan Stanley raised their price objective on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday, October 12th. Robert W. Baird upped their target price on Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. UBS Group reissued a “buy” rating and set a $260.00 price target on shares of Danaher in a research report on Thursday, October 22nd. Royal Bank Of Canada increased their price target on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Finally, DZ Bank downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $242.91.

Read Our Latest Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.